Literature DB >> 15081534

Dendritic cells in the initiation of immune responses against central nervous system-derived antigens.

Jozsef Karman1, Changying Ling, Matyas Sandor, Zsuzsa Fabry.   

Abstract

Antigen presentation is essential for the activation and maintenance of antigen-specific T cell responses in the nervous tissue. Generally, it is becoming well accepted that the antigen presenting cell (APC) type responsible for the initiation of the primary immune response through the exclusive ability to activate naïve T cells is the dendritic cell (DC); however, the role of these cells in central nervous system (CNS) immunity is unclear at this time. The diverse phenotypes and origins of DCs make the characterization of their function in the CNS even more difficult. It is believed that DCs can influence the immune response in several ways: these cells are not only capable of initiating the immune response but they are also a major determinant of peripheral tolerance. DCs are characterized by the constitutive ability to express MHC class II molecules as well as high-level upregulation of these molecules in response to inflammatory stimuli. A pan DC marker that has proved to be useful in identifying them is CD11c (the alpha-chain of CR4); other markers include CD205 and MHC class II. DCs also actively participate in the humoral immune response. In this review, we would like to discuss how DCs appear in the CNS and their roles in initiation, maintenance and tolerance in the immune reactions in the CNS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081534     DOI: 10.1016/j.imlet.2003.10.017

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  26 in total

Review 1.  Innate-adaptive crosstalk: how dendritic cells shape immune responses in the CNS.

Authors:  Benjamin D Clarkson; Erika Héninger; Melissa G Harris; JangEun Lee; Matyas Sandor; Zsuzsanna Fabry
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  Androgens suppress antigen-specific T cell responses and IFN-γ production during intracranial LCMV infection.

Authors:  Adora A Lin; Sara E Wojciechowski; David A Hildeman
Journal:  J Neuroimmunol       Date:  2010-09-14       Impact factor: 3.478

Review 3.  Myeloid Cells in the Central Nervous System.

Authors:  Jasmin Herz; Anthony J Filiano; Ashtyn Smith; Nir Yogev; Jonathan Kipnis
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

4.  Immunomodulation strategies for preventing vascular disease of the brain and heart: workshop summary.

Authors:  John Hallenbeck; Gregory Del Zoppo; Tom Jacobs; Antoine Hakim; Stephen Goldman; Ursula Utz; Ahmed Hasan
Journal:  Stroke       Date:  2006-11-02       Impact factor: 7.914

Review 5.  Sensing the microenvironment of the central nervous system: immune cells in the central nervous system and their pharmacological manipulation.

Authors:  Zsuzsanna Fabry; Heidi A Schreiber; Melissa G Harris; Matyas Sandor
Journal:  Curr Opin Pharmacol       Date:  2008-09-02       Impact factor: 5.547

6.  In situ activation of antigen-specific CD8+ T cells in the presence of antigen in organotypic brain slices.

Authors:  Changying Ling; Yakov I Verbny; Matthew I Banks; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

7.  Regional Distribution of CNS Antigens Differentially Determines T-Cell Mediated Neuroinflammation in a CX3CR1-Dependent Manner.

Authors:  Aditya Rayasam; Julie A Kijak; McKenna Dallmann; Martin Hsu; Nicole Zindl; Anders Lindstedt; Leah Steinmetz; Jeffrey S Harding; Melissa G Harris; Jozsef Karman; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Neurosci       Date:  2018-06-29       Impact factor: 6.167

8.  Gamma interferon signaling in macrophage lineage cells regulates central nervous system inflammation and chemokine production.

Authors:  Adora A Lin; Pulak K Tripathi; Allyson Sholl; Michael B Jordan; David A Hildeman
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

9.  Indications for cellular migration from the central nervous system to its draining lymph nodes in CD11c-GFP+ bone-marrow chimeras following EAE.

Authors:  Fridtjof Schiefenhövel; Kerstin Immig; Carolin Prodinger; Ingo Bechmann
Journal:  Exp Brain Res       Date:  2017-04-18       Impact factor: 1.972

Review 10.  Overview of cellular immunotherapy for patients with glioblastoma.

Authors:  Elodie Vauleon; Tony Avril; Brigitte Collet; Jean Mosser; Véronique Quillien
Journal:  Clin Dev Immunol       Date:  2010-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.